Pharmaceutical Chemistry

This track focuses on the design and application of nanoscale materials to enhance drug delivery, targeting, and therapeutic performance. It covers nanoparticles, liposomes, nanocarriers, polymeric systems, and metallic nanomaterials engineered to improve solubility, stability, and controlled release. The session highlights strategies for crossing biological barriers such as the blood–brain barrier, reducing toxicity, and increasing drug specificity. Emerging topics include nanodiagnostics, nano-bio interactions, and regulatory considerations for nanomedicine. This track showcases how nanotechnology is transforming modern drug development and precision therapeutics.

This track focuses on the chemical and molecular mechanisms that regulate brain function and influence neurological health. It covers neurotransmitter chemistry, signaling pathways, synaptic processes, and the biochemical basis of neurological and neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and epilepsy. The session highlights the design of neuroactive drugs, blood–brain barrier (BBB) targeting strategies, and biomarkers for CNS diseases. Emphasis is placed on advancing therapeutic approaches that leverage neurochemical insights to improve diagnosis, treatment, and CNS drug delivery.

This track explores the design, synthesis, and therapeutic applications of metal-based drugs and bioinorganic compounds. It highlights how metal ions and coordination complexes can offer unique reactivity, selectivity, and mechanisms of action not achievable with purely organic molecules. Key topics include anticancer metallodrugs, antimicrobial metal complexes, metal–protein interactions, redox-active therapeutics, and strategies to optimize stability, targeting, and biocompatibility. The session also covers structural characterization, ligand design, and emerging advances in metallopharmaceutical research aimed at developing more effective and innovative metal-based therapies.

This track focuses on the chemical and molecular principles underlying modern immunotherapies and vaccine technologies. It covers the design of antigenic molecules, adjuvants, antibody-based therapeutics, and immune‐modulating compounds. Key topics include antibody engineering, peptide- and carbohydrate-based immunogens, conjugate vaccines, and the chemical strategies used to enhance immune targeting, stability, and efficacy. The session also highlights emerging immunochemical approaches for cancer therapy, infectious disease prevention, and autoimmune disorder management, showcasing how chemistry drives innovation in next-generation immunotherapeutic solutions.

This track focuses on the design, synthesis, modification, and characterization of peptides and proteins used as therapeutic agents. It covers solid-phase peptide synthesis, recombinant protein production, peptide engineering, and strategies to improve stability, bioavailability, and target specificity. Key discussions include peptide–protein interactions, structural analysis, folding mechanisms, and the development of biologics such as antibodies, enzymes, and peptide-based drug candidates. The session highlights innovative analytical tools and emerging technologies that drive the creation of next-generation peptide and protein therapeutics

This track focuses on the analytical methods and quality assurance practices essential for ensuring the safety, efficacy, and consistency of pharmaceutical products. It covers advanced analytical techniques such as chromatography, spectroscopy, and mass spectrometry used to identify and quantify drug substances, impurities, and degradation products. The session highlights method validation, stability testing, quality control procedures, and regulatory standards like GMP and ICH guidelines. Emphasis is placed on building robust analytical frameworks that support product development, manufacturing reliability, and compliance throughout the pharmaceutical lifecycle.

This track focuses on environmentally responsible approaches to chemical synthesis and pharmaceutical manufacturing. It highlights eco-friendly reaction methods, renewable raw materials, energy-efficient processes, and waste-minimizing technologies that reduce the environmental footprint of drug production. Discussions include green solvents, catalytic alternatives, process intensification, and the application of sustainability principles in API synthesis, formulation, and packaging. The session emphasizes how adopting green chemistry enhances safety, efficiency, regulatory compliance, and long-term sustainability in the pharmaceutical industry.

This track explores the biological and biochemical foundations that support pharmaceutical research and drug development. It covers microbial systems, enzyme mechanisms, metabolic pathways, and biochemical interactions that influence drug action, efficacy, and safety. Key topics include antimicrobial resistance, pathogenic mechanisms, biochemical assays, microbial fermentation, and the use of microorganisms in producing therapeutic compounds. The session also highlights how biochemical insights and microbial studies guide the discovery of new drug targets, support vaccine development, and enhance biopharmaceutical production.

This track focuses on the application of forensic analytical techniques to ensure the authenticity, safety, and quality of pharmaceutical products. It covers the detection of counterfeit medicines, identification of impurities and adulterants, investigation of drug tampering, and analysis of illegal or diverted pharmaceuticals. Topics include advanced spectroscopic, chromatographic, and mass spectrometric methods used to trace chemical signatures, verify formulation integrity, and support regulatory and legal investigations. The session emphasizes the role of forensic chemistry in safeguarding public health, maintaining supply-chain security, and ensuring compliance with global pharmaceutical standards.

This track focuses on innovative in-silico methods that drive modern pharmaceutical research. It covers tools such as molecular docking, dynamics simulations, and quantum chemical calculations used to predict molecule behaviour and design more effective drug candidates. By integrating structural biology with computational modelling, this track showcases how researchers can visualize molecular interactions, improve compound stability, and accelerate the early stages of drug development.

This track focuses on the structural and physicochemical properties of solid-state pharmaceutical materials, emphasizing how crystallography—especially X-ray diffraction—reveals molecular arrangements, polymorphs, and crystal structures that influence drug stability, solubility, and bioavailability. It covers key concepts such as polymorphism, co-crystals, amorphous forms, and salt formation, along with analytical methods and crystal engineering strategies used to predict, design, and optimize solid-state behavior. The session highlights how solid-state insights support formulation development, enhance product performance, and ensure regulatory compliance through precise characterization.

This track focuses on how the three-dimensional arrangement of atoms in a molecule influences its pharmacological behaviour. It highlights the importance of stereochemistry in determining drug–receptor interactions, potency, selectivity, and metabolic pathways. Discussions include enantioselective synthesis, chiral catalysts, stereoisomer separation techniques, and analytical tools used to characterize chiral compounds. The track also emphasizes regulatory considerations, safety evaluations of individual enantiomers, and modern strategies for designing stereochemically optimized therapeutic agents.

This track highlights the application of quantum mechanical principles to understand molecular behavior and accelerate drug discovery. It focuses on computational methods such as density functional theory (DFT), quantum molecular simulations, and electronic structure analysis to predict reactivity, binding interactions, and physicochemical properties of drug candidates. By enabling precise modeling of molecular energetics and interactions at the atomic level, quantum chemistry provides deeper insights into lead optimization, reaction mechanisms, and target–ligand binding. The track emphasizes emerging quantum computing tools, hybrid QM/MM approaches, and their growing role in designing more selective and efficient therapeutics.

This track focuses on the development and optimization of practical, scalable, and cost-effective chemical processes for manufacturing active pharmaceutical ingredients (APIs). It covers route selection, reaction optimization, impurity profiling, and process safety evaluation. Emphasis is placed on green chemistry principles, robust process design, and the transition from laboratory-scale synthesis to commercial production. The track also highlights regulatory considerations, quality control strategies, and the integration of new technologies—such as flow chemistry and automation—to enhance efficiency, sustainability, and product quality in pharmaceutical manufacturing.

This track explores the synthesis, characterization, and application of porous materials—such as zeolites, metal–organic frameworks (MOFs), and other catalytic frameworks—in pharmaceutical chemistry. These materials offer high surface area, tunable pore structures, and strong catalytic properties that support drug synthesis, separation processes, and controlled delivery systems. The session highlights innovations in material engineering, catalytic efficiency, adsorption behavior, and the development of next-generation porous platforms for sustainable and efficient pharmaceutical applications.

This track focuses on the design, synthesis, and application of radioactive compounds used for diagnosis and therapy. It covers radiolabeling techniques, isotope selection, and the development of targeted radiopharmaceuticals for imaging modalities such as PET and SPECT. The track highlights advancements in theranostic agents, radiometal chelation chemistry, and quality control processes essential for safety and regulatory compliance. Emphasis is placed on innovative approaches that enhance precision imaging and targeted radiotherapy for various diseases, including cancer.

This track explores the chemical analysis of biological samples to support disease diagnosis, prognosis, and therapeutic monitoring. It emphasizes the discovery and validation of biomarkers that can accurately reflect physiological and pathological states. Topics include advanced analytical techniques, biochemical assay development, biomarker-based diagnostics, and their role in personalized and precision medicine. The track highlights innovative research that connects clinical laboratory science with improved patient outcomes.

This track focuses on the design, synthesis, and optimization of bioactive molecules with therapeutic potential. It covers modern synthetic strategies, rational drug design principles, and the development of novel chemical scaffolds. Discussions include structure–activity relationships (SAR), synthetic pathway innovations, and the integration of computational tools to accelerate the creation of effective and safer drug candidates. The track highlights cutting-edge approaches that bridge synthetic chemistry with medicinal applications.

This track highlights the crucial role of natural products and plant-derived phytochemicals in the development of novel therapeutics. It explores how bioactive compounds from medicinal plants, marine sources, and microorganisms serve as valuable leads for drug discovery. Discussions include isolation techniques, structural characterization, biological screening, and the modification of natural molecules to enhance potency and safety. With increasing interest in sustainable and nature-inspired drug design, this track showcases how traditional knowledge, modern analytical tools, and advanced screening technologies combine to create innovative and effective drug candidates.